Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluation of cardiometabolic factors in heart failure patients

Official title: Cardiometabolic Risk Factors and Clinical Outcomes in Heart Failure: An Observational Cohort Study

Run by Ruijin Hospital · NCT06939985 · Data updated 2026-11-12

This study looks at how different health factors related to metabolism and body fat affect heart function and outcomes in people with heart failure.

More Heart Failure trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment5000 (estimated)
SponsorRuijin Hospital
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedJanuary 1, 2015
Main results expectedMay 31, 2027
Study endsMay 31, 2030
Registry record updatedApril 23, 2025
Trial IDNCT06939985 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with chronic heart failure across various ejection fraction phenotypes.

Probably not a fit

Patients with an estimated survival of less than one year or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study investigates the impact of systemic and local cardiometabolic risk factors on cardiac remodeling and clinical outcomes in heart failure patients. It combines retrospective clinical data from the past decade with a 5-year prospective follow-up, examining various heart failure phenotypes including HFrEF, HFmrEF, HFpEF, and HFimpEF. The study analyzes metabolic factors such as blood lipid profiles and insulin resistance, alongside localized factors like epicardial and perivascular adipose tissue, to understand their associations with cardiac function and adverse cardiovascular events.

Why it matters

Potential benefit: If successful, this study could enhance risk stratification and management strategies for heart failure patients.

How similar studies have gone: Other studies have shown success in evaluating cardiometabolic factors in heart failure, but this study's comprehensive approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years
2. Chronic HF (NYHA II\~IV), including:

   * HFrEF (HF with reduced ejection fraction): ① HF symptoms±signs ; ② LVEF≤40%.
   * HFimpEF (HF with improved ejection fraction): ① HF symptoms±signs; ② previous LVEF ≤ 40% and a follow-up measurement of LVEF \>40%.
   * HFmrEF (HF with mildly reduced ejection fraction): ① HF symptoms±signs; ② LVEF 41%\~49%.
   * HFpEF (HF with preserved ejection fraction): ① HF symptoms±signs; ② LVEF ≥50%; ③ objective evidence of cardiac structural and/or functional abnormalities consistent with the presence of LV diastolic dysfunction/raised LV filling pressures, including raised natriuretic peptide.

Exclusion Criteria:

1. Estimated survival ≤ 1 year.
2. Pregnant or lactation, or have the intention to give birth within one year.
3. Poor compliance, unable to follow-up.
4. Mental or physical status not allowing written informed consent.
5. Unwillingness to give informed consent.

Where it's running

  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.